Cargando…

Correction to: A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease

Detalles Bibliográficos
Autores principales:	Holden, Sean, Maksoud, Rebekah, Eaton-Fitch, Natalie, Cabanas, Hélène, Staines, Donald, Marshall-Gradisnik, Sonya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590658/ https://www.ncbi.nlm.nih.gov/pubmed/33109201 http://dx.doi.org/10.1186/s12967-020-02575-7

Ejemplares similares

A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease
por: Holden, Sean, et al.
Publicado: (2020)

Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)
por: Corbitt, Matthew, et al.
Publicado: (2019)

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

Impact of Life Stressors on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms: An Australian Longitudinal Study
por: Balinas, Cassandra, et al.
Publicado: (2021)

A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID)
por: Huth, Teilah Kathryn, et al.
Publicado: (2020)

A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques
por: Maksoud, Rebekah, et al.
Publicado: (2020)

A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome
por: Eaton-Fitch, Natalie, et al.
Publicado: (2019)

Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review
por: Maksoud, Rebekah, et al.
Publicado: (2023)

A systematic review and meta-analysis of urinary biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
por: Taccori, Asher, et al.
Publicado: (2023)

A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life
por: Weigel, Breanna, et al.
Publicado: (2021)

Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP(2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Du Preez, Stanley, et al.
Publicado: (2021)

The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP(2) and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Eaton-Fitch, Natalie, et al.
Publicado: (2021)

Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment
por: Cabanas, Helene, et al.
Publicado: (2021)

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Eaton-Fitch, Natalie, et al.
Publicado: (2022)

Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation
por: Eaton, Natalie, et al.
Publicado: (2018)

Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Balinas, Cassandra, et al.
Publicado: (2019)

Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Cabanas, Hélène, et al.
Publicado: (2018)

A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
por: Du Preez, S., et al.
Publicado: (2018)

Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients
por: Thapaliya, Kiran, et al.
Publicado: (2023)

Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review
por: Du Preez, Stanley, et al.
Publicado: (2021)

Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients
por: Cabanas, H., et al.
Publicado: (2019)

Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Cabanas, Helene, et al.
Publicado: (2019)

Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study
por: Eaton-Fitch, N., et al.
Publicado: (2020)

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis
por: Johnston, Samantha, et al.
Publicado: (2013)

Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients
por: Johnston, Samantha C, et al.
Publicado: (2016)

Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Du Preez, Stanley, et al.
Publicado: (2023)

Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Brenu, Ekua W, et al.
Publicado: (2011)

The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort
por: Close, Shara, et al.
Publicado: (2020)

Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2021)

Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
por: Sukocheva, Olga A., et al.
Publicado: (2021)

Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Sasso, Etianne Martini, et al.
Publicado: (2022)

High-Throughput Sequencing of Plasma MicroRNA in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Brenu, Ekua W., et al.
Publicado: (2014)

Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Chacko, Anu, et al.
Publicado: (2016)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Peterson, D., et al.
Publicado: (2015)

Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d5did56pc6flmj33g3c26u34ri